11/14/2024
8:00 PM | Redmile Group, LLC (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:42 AM | Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
7:33 AM | Repare Therapeutics (Filer)
| Form 424B5 | |
11/07/2024
6:10 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:15 AM | Repare Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
11:15 PM | Repare Therapeutics (Filer)
| Form EFFECT | |
08/07/2024
8:06 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/06/2024
3:41 PM | Repare Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/06/2024
3:20 PM | Repare Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2024
3:27 PM | Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
3:36 PM | Repare Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Bonita David P (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Kulkarni Samarth (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Morrison Briggs (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:35 PM | Repare Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:06 PM | Repare Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/26/2024
3:14 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:27 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:28 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:30 PM | Forte Steve (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
8:31 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:54 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:56 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:57 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
5:59 PM | Forte Steve (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
11:37 AM | Forte Steve (Reporting)
Repare Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
1:50 PM | Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
6:25 PM | Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:23 PM | Koehler Maria (Reporting)
Repare Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:23 PM | Repare Therapeutics (Subject)
Zinda Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
8:02 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:04 PM | Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:06 PM | Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:10 AM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:15 AM | Repare Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
8:02 PM | Blue Owl Capital Holdings LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:54 AM | Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024
3:01 PM | ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
| Form SC 13G/A | |
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad) Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming.
The question is: Why aren't you taking action, too? Click Here For Your Free Guide |
01/25/2024
1:29 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:05 PM | Repare Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:19 PM | Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:52 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
| Form SC 13D/A | |
11/17/2023
3:54 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free RPTX Stock Alerts